109 related articles for article (PubMed ID: 3140109)
1. Is nodular regenerative hyperplasia of the liver associated with azathioprine therapy after renal transplantation?
Jones MC; Best PV; Catto GR
Nephrol Dial Transplant; 1988; 3(3):331-3. PubMed ID: 3140109
[TBL] [Abstract][Full Text] [Related]
2. [Nodular regenerative hyperplasia of the liver associated with azathioprine therapy].
Duvoux C; Kracht M; Lang P; Vernant JP; Zafrani ES; Dhumeaux D
Gastroenterol Clin Biol; 1991; 15(12):968-73. PubMed ID: 1783253
[TBL] [Abstract][Full Text] [Related]
3. Three cases of nodular regenerative hyperplasia of the liver following renal transplantation.
Buffet C; Cantarovitch M; Pelletier G; Fabre M; Martin E; Charpentier B; Etienne JP; Fries D
Nephrol Dial Transplant; 1988; 3(3):327-30. PubMed ID: 3140108
[TBL] [Abstract][Full Text] [Related]
4. Thiopurine-methyltransferase and inosine triphosphate pyrophosphatase polymorphism in a liver transplant recipient developing nodular regenerative hyperplasia on low-dose azathioprine.
Buster EH; van Vuuren HJ; Zondervan PE; Metselaar HJ; Tilanus HW; de Man RA
Eur J Gastroenterol Hepatol; 2008 Jan; 20(1):68-72. PubMed ID: 18090994
[TBL] [Abstract][Full Text] [Related]
5. [Nodular regenerative hyperplasia as a side effect of azathioprine in a patient with Crohn's disease].
Schumann M; Preiss JC; Loddenkemper C; Günther U; Somasundaram R; Siegmund B; Zeitz M
Dtsch Med Wochenschr; 2008 Sep; 133(38):1897-900. PubMed ID: 18788068
[TBL] [Abstract][Full Text] [Related]
6. [Cholestasis after renal transplantation and immune-suppressive therapy (author's transl)].
Schmidt P; Balcke P; Zazgornik J; Kopsa H; Altrichter H; Türk H
Leber Magen Darm; 1979 Feb; 9(1):11-4. PubMed ID: 368472
[TBL] [Abstract][Full Text] [Related]
7. Nodular regenerative hyperplasia and thiopurines: the case for level-dependent toxicity.
de Boer NK; Mulder CJ; van Bodegraven AA
Liver Transpl; 2005 Oct; 11(10):1300-1. PubMed ID: 16184561
[No Abstract] [Full Text] [Related]
8. Absence of nodular regenerative hyperplasia after low-dose 6-thioguanine maintenance therapy in inflammatory bowel disease patients.
de Boer NK; Zondervan PE; Gilissen LP; den Hartog G; Westerveld BD; Derijks LJ; Bloemena E; Engels LG; van Bodegraven AA; Mulder CJ
Dig Liver Dis; 2008 Feb; 40(2):108-13. PubMed ID: 18083079
[TBL] [Abstract][Full Text] [Related]
9. [Isolated erythroid aplasia during immunosuppressive therapy with azathioprine after kidney transplantation].
Flury W; Montandon A
Schweiz Med Wochenschr; 1980 Nov; 110(44):1614-6. PubMed ID: 7006074
[TBL] [Abstract][Full Text] [Related]
10. Peliosis hepatis and nodular regenerative hyperplasia of the liver in renal transplant recipients.
Ihara H; Ichikawa Y; Nagano S; Fukunishi T; Shinji Y
Med J Osaka Univ; 1982 Sep; 33(1-2):13-8. PubMed ID: 6759897
[No Abstract] [Full Text] [Related]
11. [Chronic myeloid leukemia after renal transplantation: report of a new case and review of the bibliography].
Sanz L; Cervantes F; Esteve J; Vilardell J; Marín P; Rozman C; Montserrat E
Sangre (Barc); 1996 Oct; 41(5):391-3. PubMed ID: 9026925
[TBL] [Abstract][Full Text] [Related]
12. Results of liver transplantation for nodular regenerative hyperplasia.
Radomski JS; Chojnacki KA; Moritz MJ; Rubin R; Armenti VT; Wilson GA; Herrine S; Conn M
Am Surg; 2000 Nov; 66(11):1067-70. PubMed ID: 11090022
[TBL] [Abstract][Full Text] [Related]
13. Nodular regenerative hyperplasia: a controversial indication for orthotopic liver transplantation.
Elariny HA; Mizrahi SS; Hayes DH; Boudreaux JP; Hussey JL; Farr GH
Transpl Int; 1994 Jul; 7(4):309-13. PubMed ID: 7916934
[TBL] [Abstract][Full Text] [Related]
14. [Hepatic veno-occlusive disease associated to the use of azathioprine in a renal transplant recipient].
Hola K; Brahm J; Alvo M; Cotera A; Passalacqua W; Smok G
Rev Med Chil; 1996 Dec; 124(12):1489-91. PubMed ID: 9334484
[TBL] [Abstract][Full Text] [Related]
15. Nodular regenerative hyperplasia of the liver secondary to azathioprine in a patient with inflammatory bowel disease.
Bryant DL; Miles CJ; Gearry RB
N Z Med J; 2010 Apr; 123(1313):74-6. PubMed ID: 20581898
[TBL] [Abstract][Full Text] [Related]
16. Orthotopic liver transplantation in 4 patients with portal hypertension and non-cirrhotic nodular liver.
Loinaz C; Colina F; Musella M; Lopez-Rios F; Gomez R; Jimenez C; Gonzalez Pinto I; Garcia I; Moreno Gonzalez E
Hepatogastroenterology; 1998; 45(23):1787-94. PubMed ID: 9840149
[TBL] [Abstract][Full Text] [Related]
17. Role of endothelial cell injury in the spectrum of azathioprine-induced liver disease after renal transplant: light microscopy and ultrastructural observations.
Haboubi NY; Ali HH; Whitwell HL; Ackrill P
Am J Gastroenterol; 1988 Mar; 83(3):256-61. PubMed ID: 3278593
[TBL] [Abstract][Full Text] [Related]
18. Significance of nodular regenerative hyperplasia occurring de novo following liver transplantation.
Devarbhavi H; Abraham S; Kamath PS
Liver Transpl; 2007 Nov; 13(11):1552-6. PubMed ID: 17969192
[TBL] [Abstract][Full Text] [Related]
19. Nodular regenerative hyperplasia of the liver: the importance of combined macroscopic and microscopic findings.
Forbes GM; Shilkin KB; Reed WD
Med J Aust; 1991 Mar; 154(6):415-7. PubMed ID: 2000057
[TBL] [Abstract][Full Text] [Related]
20. Azathioprine induced liver disease: nodular regenerative hyperplasia of the liver and perivenous fibrosis in a patient treated for multiple sclerosis.
Mion F; Napoleon B; Berger F; Chevallier M; Bonvoisin S; Descos L
Gut; 1991 Jun; 32(6):715-7. PubMed ID: 2060883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
